Increases in collagen type I synthesis in asthma: The role of eosinophils and transforming growth factor-β

Clinical and Experimental Allergy

Volumn 32, Issue 6, 2002, Pages 860-865

  Nomura, A ^a   Uchida, Y ^a   Sakamoto, T ^a   Ishii, Y ^a   Masuyama, K ^a   Morishima, Y ^a   Hirano, K ^a   Sekizawa, K ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Asthma; Collagen; Eosinophils; Sputum; Transforming growth factor

Indexed keywords

COLLAGEN TYPE 1; PEPTIDE; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALLERGIC ASTHMA; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL COUNT; CLINICAL ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 0036279977     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2745.2002.01404.x     Document Type: Article

References (28)

1. Asthma: A dynamic disease of inflammation and repair
2. Asthma. From bronchoconstriction to airways inflammation and remodeling
3. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population
4. Rate of decline of lung function in subjects with asthma
5. The mechanics of airway narrowing in asthma
6. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen 1 biosynthesis in bone: Correlation with iliac bone formation rates and comparison with total alkaline phosphatase
7. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases
8. Changes in collagen turnover in early acute respiratory distress syndrome
9. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry
10. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer
11. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy- and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer
12. The transforming growth factor-β family
13. Instability of myofibroblast phenotype in culture
14. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma
15. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma
16. The clinical standard of parameters in pulmonary function test
17. Use of induced sputum cell count to investigate airway inflammation in asthma
18. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects
19. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding
20. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: A role for transforming growth factor-β (TGF-β)
21. The carboxyl fragment released by bacterial collagenase from human type I procollagen: Antibodies to the propeptide determinants
22. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma
23. Inhaled IL-5 increases concentrations of soluble intracellular adhesion molecule-1 in sputum from atopic asthmatic subjects
24. Airway remodeling is a distinctive feature of asthma and is related to severity of disease
25. Subepithelial fibrosis in the bronchi of asthmatics
26. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease
27. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma